A micropenis is a penis that measures less than 2.5 standard deviations below the average stretched length for a given age. In practical terms, that means shorter than about 2.5 cm (just under 1 inch) in a newborn, or shorter than roughly 9.3 cm (about 3.7 inches) when stretched in an adult. The condition is uncommon, estimated to affect fewer than 1 in 200 male births, and it is typically identified at birth during a routine physical exam.
How Micropenis Is Measured
The measurement that matters is called “stretched penile length,” not erect length or flaccid length at rest. A clinician presses a ruler firmly against the pubic bone (to eliminate any fat pad), gently stretches the penis to its full extent without causing discomfort, and measures from the base to the tip of the glans. This stretched measurement closely approximates erect length and gives a consistent, reproducible number.
If you want to estimate your own stretched penile length, the technique is straightforward. Place one hand flat over the area above the penis to press back the fat pad. With your other hand, retract the foreskin and hold the head of the penis between your thumb and forefinger. Extend the penis forward, away from your body, until it is fully stretched but not painful. Measure from the pubic bone to the tip.
Size Thresholds by Age
The cutoff shifts with age because the penis grows throughout childhood and adolescence. For a full-term newborn, the average stretched penile length is about 3.5 cm, so the micropenis threshold sits around 2.5 cm. Published studies show some variation in newborn cutoffs, with reported thresholds ranging from 1.75 cm to 2.9 cm depending on the population studied.
For adults, the threshold is approximately 7 to 9.3 cm (roughly 2.75 to 3.7 inches) stretched, depending on which reference data a clinician uses. A penis that falls below this range, with otherwise normal anatomy, meets the clinical definition. Importantly, the diagnosis requires that the penis is structurally normal: it has a typical shape, a urethral opening in the correct position, and no curvature or other anatomical differences. If the penis is small and also has structural abnormalities, the evaluation shifts toward a broader category of conditions.
What Causes It
Most cases trace back to hormonal factors during fetal development. The penis grows most rapidly during the second and third trimesters of pregnancy, driven by testosterone and a related hormone called dihydrotestosterone. If the fetal testes don’t produce enough testosterone, or if the brain doesn’t send the right hormonal signals to trigger that production, the penis may not reach its expected size before birth.
One well-known example is Kallmann syndrome, a genetic condition where the nerve cells responsible for triggering sex hormone production don’t migrate to the correct part of the brain during fetal development. Boys born with Kallmann syndrome often have a micropenis along with undescended testes and, characteristically, a reduced or absent sense of smell. Changes in more than 20 different genes have been linked to this syndrome alone.
Other causes include problems with the pituitary gland (the small structure at the base of the brain that orchestrates hormone release), conditions where the body’s tissues don’t respond normally to testosterone, and certain chromosomal differences. In some cases, no clear cause is found.
How It Affects Daily Life
A micropenis functions normally in most respects. Urination is unaffected, and erections occur as they would with a typically sized penis. Sexual intercourse is possible, though some positions or techniques may work better than others. The psychological impact, particularly feelings of self-consciousness or anxiety around intimacy, tends to be the more significant concern for many men and can be addressed through counseling or therapy.
Fertility can be affected, but this depends on the underlying cause rather than the size itself. If the micropenis resulted from low testosterone or another hormonal deficiency, sperm production may also be reduced. Men whose micropenis is linked to conditions like Kallmann syndrome may need hormone treatment to support fertility.
Treatment in Infancy
When micropenis is identified in a newborn, the first-line treatment is a short course of testosterone. This is typically given as a monthly injection over three months, or as a topical cream applied several times daily for three to six weeks. The goal is to stimulate penile growth during infancy, taking advantage of the tissue’s sensitivity to hormones early in life. Most infants respond well, with the penis growing into a more typical size range.
The type of testosterone preparation matters in infants. Certain formulations contain ingredients like benzyl alcohol or propylene glycol that can be toxic to newborns, so clinicians use specific preparations designed to be safe for this age group.
Options for Older Children and Adults
If the condition wasn’t treated in infancy, or if the initial treatment didn’t produce sufficient growth, testosterone therapy can be tried again around puberty. The hormonal surge of puberty naturally drives penile growth, and supplemental testosterone can amplify this effect in boys whose own production is low.
For adults who did not respond adequately to hormone therapy, surgical options exist. Penile lengthening procedures can release the suspensory ligament that anchors the penis to the pubic bone, allowing more of the internal shaft to extend outward. These surgeries carry risks including scarring and changes in sensation, and results vary. Penile prostheses, which are implants placed inside the shaft, are another option and can simultaneously address erectile difficulties if they are present.
The choice between hormone therapy and surgery depends on the individual’s age, the underlying cause, and how much growth hormone treatment has already achieved. For many men, the stretched length after treatment falls within or close to the typical range, and no further intervention is needed.